LLY

Eli Lilly & Co.

XNYS · CS

Volume—

Market cap$1,018.9B

Market position18.41%

Support / resistance$1,141.26 / $1,156.55

About Eli Lilly & Co.

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

Explore LLY

Open the interactive ticker terminal for charts, technical tools, market discussion and live modules.

Open LLY ticker terminal